Market Tracker

03/03 6:02pm ET

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

During the Trading Day
106.91 +1.51 / +1.43%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
105.17 -1.74 / -1.63%
 
Volume: 3.3K

Today’s Trading

Previous close105.40
Today’s open105.98
Day’s range102.90 - 107.23
Volume437,572
Average volume (3 months)718,475
Market cap$8.8B
Dividend yield--
Data as of 3:59pm ET, 03/03/2015

Growth & Valuation

Earnings growth (last year)-234.48%
Earnings growth (this year)+37.33%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+7.20%
P/E ratioNM
Price/Sales142.50
Price/Book8.69

Competitors

 Today’s
change
Today’s
% change
QQuintiles Transnatio...0.000.00%
ISISIsis Pharmaceuticals...+1.86+2.78%
ICLRICON PLC-1.35-1.94%
CRLCharles River Labora...-1.13-1.47%
Data as of 4:04pm ET, 03/03/2015

Financials

Next reporting dateMay 4, 2015
EPS forecast (this quarter)-$0.68
Annual revenue (last year)$50.6M
Annual profit (last year)-$360.4M
Net profit margin-712.79%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John M. Maraganore
President &
Chief Operating Officer
Barry E. Greene
Corporate headquarters
Cambridge, Massachusetts

Forecasts